• Kate E Stanley, Elizabeth Thomas, Megan Leaver, and Dagan Wells.
• Nuffield Department of Women's and Reproductive Health, University of Oxford, John Radcliffe Hospital, Women's Centre, Oxford, United Kingdom.
• Fertil. Steril. 2020 Jul 1; 114 (1): 33-43.

ObjectiveTo identify cell types in the male and female reproductive systems at risk for SARS-CoV-2 infection because of the expression of host genes and proteins used by the virus for cell entry.DesignDescriptive analysis of transcriptomic and proteomic data.SettingAcademic research department and clinical diagnostic laboratory.Patient(S)Not applicable (focus was on previously generated gene and protein expression data).Intervention(S)None.Main Outcome Measure(S)Identification of cell types coexpressing the key angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) genes and proteins as well as other candidates potentially involved in SARS-CoV-2 cell entry.Result(S)On the basis of single-cell RNA sequencing data, coexpression of ACE2 and TMPRSS2 was not detected in testicular cells, including sperm. A subpopulation of oocytes in nonhuman primate ovarian tissue was found to express ACE2 and TMPRSS2, but coexpression was not observed in ovarian somatic cells. RNA expression of TMPRSS2 in 18 samples of human cumulus cells was shown to be low or absent. There was general agreement between publicly available bulk RNA and protein datasets in terms of ACE2 and TMPRSS2 expression patterns in testis, ovary, endometrial, and placental cells.Conclusion(S)These analyses suggest that SARS-CoV-2 infection is unlikely to have long-term effects on male and female reproductive function. Although the results cannot be considered definitive, they imply that procedures in which oocytes are collected and fertilized in vitro are associated with very little risk of viral transmission from gametes to embryos and may indeed have the potential to minimize exposure of susceptible reproductive cell types to infection in comparison with natural conception.Copyright © 2020 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

54 keywords...

hide…